Filip Dubovsky
Chief Tech/Sci/R&D Officer bij NOVAVAX, INC.
Vermogen: 329 068 $ op 29-02-2024
Profiel
Momenteel bekleedt Filip Dubovsky de functie van Chief Medical Officer & Executive Vice President bij Novavax, Inc. Hij zit ook in de raad van bestuur van het Albert B. Sabin Vaccine Institute, Inc.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NOVAVAX, INC.
0.06% | 10-03-2024 | 66 613 ( 0.06% ) | 329 068 $ | 29-02-2024 |
Actieve functies van Filip Dubovsky
Bedrijven | Functie | Begin |
---|---|---|
NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 17-06-2020 |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Director/Board Member | - |
Eerdere bekende functies van Filip Dubovsky
Bedrijven | Functie | Einde |
---|---|---|
ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 01-01-2020 |
Opleiding van Filip Dubovsky
The Johns Hopkins University | Undergraduate Degree |
The University of Alabama | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
NOVAVAX, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |